Publication | Open Access
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
28
Citations
39
References
2011
Year
These data indicate that targeting PIM kinase signalling is a promising treatment strategy for RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1